| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-09 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0006 |